Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights► More than 25% of the population suffer from allergy. ► Allergen-specific immunotherapy has been performed for 100 years. ► Recombinant hypoallergenic allergen derivatives allow a reduction of side-effects. ► As allergy vaccines they can avoid IgE-mediated side effects. ► Therapeutic effects are mainly mediated by allergen-specific block...
Alternative Titles
Full title
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4571077
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4571077
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2011.11.011
